Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Pilot Study Evaluating Vaginal Dilator Use and Toxicity Following Vaginal Brachytherapy

NCT02058550 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT02058550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02058550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Pilot Study Evaluating Vaginal Dilator Use and Toxicity Following Vaginal Brachytherapy
Lead sponsor
Stanford University
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2014
Completion date
October 23, 2020
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, endometrial cancer, radiation toxicity, vaginal cancer